Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis (Frontiers in Neuroscience, (2019), 13, 10.3389/fnins.2019.00394)
Adam D. Kennedy
, Kirk L. Pappan
, Taraka Donti
, Mauricio R. Delgado
, Marwan Shinawi
, Toni S. Pearson
, Seema R. Lalani
, William J. Craigen
, V. Reid Sutton
, Anne M. Evans
, Qin Sun
, Lisa T. Emrick
, Sarah H. Elsea
Research output: Contribution to journal › Comment/debate
2Scopus
citations
Fingerprint
Dive into the research topics of 'Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis (Frontiers in Neuroscience, (2019), 13, 10.3389/fnins.2019.00394)'. Together they form a unique fingerprint.